https://www.selleckchem.com/products/myci975.html
OBJECTIVE Upper airway stimulation (UAS) is used to treat patients with moderate to severe obstructive sleep apnea (OSA). The aim of this study is to report the incidence and potential predictors of elevated central and mixed apnea index (CMAI) after UAS. STUDY DESIGN Retrospective chart review of patients undergoing UAS. SETTING Tertiary care center. SUBJECTS AND METHODS Included patients underwent UAS for OSA at our institution between 2014 and 2018. Data collected included demographic information, implantation records, and pre- and p
Like
Comment
Share
